February 2020

Adarza BioSystems Raises $25 Million in Series D Funding to Launch Platform for Research and Drug Development

Biotech company Adarza BioSystems announced today that it has raised $25 million in a Series D round co-led by 3x5 Partners, based in Portland, Ore., and St. Louis-based Lightchain Capital, LLC, the family office of Scottrade founder Rodger Riney. Adarza plans to use the funds to support full commercialization of ZIVA, its automated biological testing platform for academic and clinical research. Scheduled for commercial launch in June, the ZIVA platform will allow researchers to quickly identify inflammation, cardiovascular, and oncology protein biomarkers for disease profiling and drug development.

January 2017

March 2016

November 2014

October 2014

Adarza BioSystems Selects SunEdison Semiconductor Site for Manufacturing Immunoassay Consumables

Adarza BioSystems, Inc. has executed an agreement with SunEdison Semiconductor to establish immunoassay consumable manufacturing facilities at its St. Peters, Missouri manufacturing site.

April 2013

BioGenerator Investment Helps Adarza BioSystems Establish Operations in St. Louis

Life Science company expands presence to St. Louis ST. LOUIS, MO:  BioGenerator recently led syndication of investment in Adarza BioSystems, Inc., to support further commercialization of the company’s immunoassay products. As part of the investment, [...]

February 2013

Adarza BioSystems Awarded Federal Grant to Support Toxic Exposure Assessment Product Development

ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $245,912 Small Business Innovation Research (SBIR) grant from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) to aid the company [...]

June 2012

Missouri Technology Corporation Helps to Recruit Life Science Startup to Missouri with IDEA Funds Program

NEWS RELEASE FROM: Missouri Department of Economic Development Date: Thursday, June 27, 2012 JEFFERSON CITY, MO:  The Missouri Technology Corporation (MTC) today announced a significant investment in a life science startup company through its IDEA Funds [...]